MedTrace Logo

A Study to Learn About Metachromatic Leukodystrophy (MLD) in Children in Spain

NCT05755568 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2024-01-12

No results posted yet for this study

Summary

The main aim of this study is to learn about metachromatic leukodystrophy (MLD) in children and teenagers in Spain. This includes checking the number of new MLD cases and the frequency of children with MLD in 2022 in Spain.

There is no treatment involved in this study. Participants' data will be taken from their medical records (charts), which were already collected as a part of their routine care between 01 January 2000 and 31 December 2022.

Conditions

  • Metachromatic Leukodystrophy (MLD)

Interventions

OTHER

No Intervention

As this is an observational study, no intervention will be administered.

Sponsors & Collaborators

Principal Investigators

  • Study Director · Takeda

Eligibility

Min Age
0 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-30
Primary Completion
2024-07-01
Completion
2024-07-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05755568 on ClinicalTrials.gov